| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | scaffold protein binding | 2.56e-07 | 93 | 30 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.77e-06 | 26 | 30 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.44e-05 | 52 | 30 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.96e-04 | 14 | 30 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 5.90e-04 | 24 | 30 | 2 | GO:0043027 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 5.90e-04 | 24 | 30 | 2 | GO:0120283 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 6.38e-04 | 473 | 30 | 5 | GO:0004842 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.93e-04 | 26 | 30 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 9.11e-04 | 512 | 30 | 5 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.08e-03 | 532 | 30 | 5 | GO:0016755 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.66e-03 | 873 | 30 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.11e-03 | 171 | 30 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 2.21e-03 | 372 | 30 | 4 | GO:0061630 | |
| GeneOntologyMolecularFunction | kinase binding | 2.80e-03 | 969 | 30 | 6 | GO:0019900 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.83e-03 | 398 | 30 | 4 | GO:0061659 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 2.97e-03 | 54 | 30 | 2 | GO:0043028 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 3.66e-03 | 60 | 30 | 2 | GO:0005544 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.70e-03 | 459 | 30 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 5.53e-03 | 775 | 30 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | channel activity | 7.53e-03 | 525 | 30 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.58e-03 | 526 | 30 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 7.71e-03 | 88 | 30 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 9.15e-03 | 875 | 30 | 5 | GO:0019904 | |
| GeneOntologyBiologicalProcess | regulation of apoptosis involved in tissue homeostasis | 6.55e-06 | 3 | 31 | 2 | GO:0060785 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.12e-05 | 36 | 31 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | inhibition of cysteine-type endopeptidase activity | 9.76e-05 | 10 | 31 | 2 | GO:0097340 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.09e-04 | 62 | 31 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.15e-04 | 63 | 31 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | zymogen inhibition | 1.19e-04 | 11 | 31 | 2 | GO:0097341 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.98e-06 | 17 | 31 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.05e-05 | 29 | 31 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | early phagosome | 1.92e-04 | 14 | 31 | 2 | GO:0032009 | |
| GeneOntologyCellularComponent | T-tubule | 2.16e-04 | 79 | 31 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | node of Ranvier | 3.98e-04 | 20 | 31 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | axon initial segment | 8.43e-04 | 29 | 31 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 9.06e-04 | 785 | 31 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | Z disc | 1.43e-03 | 151 | 31 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.85e-03 | 43 | 31 | 2 | GO:0098688 | |
| GeneOntologyCellularComponent | I band | 1.88e-03 | 166 | 31 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.25e-03 | 378 | 31 | 4 | GO:0034702 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.38e-03 | 384 | 31 | 4 | GO:0030139 | |
| GeneOntologyCellularComponent | sarcolemma | 2.75e-03 | 190 | 31 | 3 | GO:0042383 | |
| HumanPheno | Gaze-evoked nystagmus | 1.52e-05 | 55 | 15 | 4 | HP:0000640 | |
| MousePheno | abnormal head movements | 4.28e-05 | 103 | 27 | 4 | MP:0000436 | |
| MousePheno | ventricular fibrillation | 7.50e-05 | 7 | 27 | 2 | MP:0006110 | |
| MousePheno | abnormal action potential | 1.16e-04 | 133 | 27 | 4 | MP:0005402 | |
| MousePheno | decreased cerebellar granule cell number | 1.60e-04 | 10 | 27 | 2 | MP:0008924 | |
| MousePheno | abnormal stationary movement | 1.71e-04 | 147 | 27 | 4 | MP:0001388 | |
| MousePheno | congestive heart failure | 2.25e-04 | 62 | 27 | 3 | MP:0006138 | |
| MousePheno | abnormal muscle physiology | 3.15e-04 | 954 | 27 | 8 | MP:0002106 | |
| MousePheno | fibrillation | 3.22e-04 | 14 | 27 | 2 | MP:0006109 | |
| Domain | Na_trans_cytopl | 8.25e-08 | 6 | 31 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 8.25e-08 | 6 | 31 | 3 | IPR024583 | |
| Domain | Na_channel_asu | 4.93e-07 | 10 | 31 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 4.93e-07 | 10 | 31 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 4.93e-07 | 10 | 31 | 3 | PF06512 | |
| Domain | IQ | 9.45e-06 | 81 | 31 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.44e-05 | 90 | 31 | 4 | IPR000048 | |
| Domain | IQ | 1.64e-05 | 93 | 31 | 4 | PS50096 | |
| Domain | BIR | 7.42e-05 | 8 | 31 | 2 | SM00238 | |
| Domain | BIR_REPEAT_2 | 7.42e-05 | 8 | 31 | 2 | PS50143 | |
| Domain | - | 7.42e-05 | 8 | 31 | 2 | 1.10.1170.10 | |
| Domain | BIR_rpt | 7.42e-05 | 8 | 31 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 7.42e-05 | 8 | 31 | 2 | PS01282 | |
| Domain | BIR | 7.42e-05 | 8 | 31 | 2 | PF00653 | |
| Domain | Channel_four-helix_dom | 1.14e-04 | 57 | 31 | 3 | IPR027359 | |
| Domain | - | 1.14e-04 | 57 | 31 | 3 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 8.79e-04 | 114 | 31 | 3 | IPR005821 | |
| Domain | Ion_trans | 8.79e-04 | 114 | 31 | 3 | PF00520 | |
| Domain | HECT | 9.12e-04 | 27 | 31 | 2 | PF00632 | |
| Domain | HECTc | 9.12e-04 | 27 | 31 | 2 | SM00119 | |
| Domain | HECT_dom | 9.12e-04 | 27 | 31 | 2 | IPR000569 | |
| Domain | HECT | 9.12e-04 | 27 | 31 | 2 | PS50237 | |
| Domain | IQ | 6.17e-03 | 71 | 31 | 2 | PF00612 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.44e-05 | 31 | 22 | 3 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.59e-05 | 32 | 22 | 3 | M27455 | |
| Pathway | REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE | 3.47e-05 | 6 | 22 | 2 | MM14489 | |
| Pathway | REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE | 4.86e-05 | 7 | 22 | 2 | MM14486 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_LOCALIZATION | 1.04e-04 | 10 | 22 | 2 | MM15539 | |
| Pathway | REACTOME_FORMATION_OF_APOPTOSOME | 1.04e-04 | 10 | 22 | 2 | MM14485 | |
| Pathway | REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE | 1.52e-04 | 12 | 22 | 2 | MM14487 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.49e-04 | 203 | 22 | 4 | M5485 | |
| Pathway | BIOCARTA_BCELLSURVIVAL_PATHWAY | 3.12e-04 | 17 | 22 | 2 | MM1353 | |
| Pathway | REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE | 3.12e-04 | 17 | 22 | 2 | MM14490 | |
| Pathway | BIOCARTA_MITOCHONDRIA_PATHWAY | 4.80e-04 | 21 | 22 | 2 | MM1484 | |
| Pathway | REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING | 5.77e-04 | 23 | 22 | 2 | MM15177 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 6.82e-04 | 25 | 22 | 2 | MM1359 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.43e-04 | 121 | 22 | 3 | M872 | |
| Pathway | WP_DRAVET_SYNDROME | 8.57e-04 | 28 | 22 | 2 | M45519 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.04e-03 | 130 | 22 | 3 | M27454 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.12e-03 | 32 | 22 | 2 | MM14975 | |
| Pathway | REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY | 1.19e-03 | 33 | 22 | 2 | MM15180 | |
| Pathway | BIOCARTA_DEATH_PATHWAY | 1.27e-03 | 34 | 22 | 2 | MM1422 | |
| Pathway | REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS | 1.34e-03 | 35 | 22 | 2 | MM15168 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.75e-03 | 40 | 22 | 2 | MM14473 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.31e-03 | 46 | 22 | 2 | M27397 | |
| Pathway | REACTOME_REGULATION_OF_TNFR1_SIGNALING | 2.41e-03 | 47 | 22 | 2 | MM15179 | |
| Pathway | WP_RETT_SYNDROME | 2.51e-03 | 48 | 22 | 2 | M39759 | |
| Pathway | PID_CASPASE_PATHWAY | 2.83e-03 | 51 | 22 | 2 | M220 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.83e-03 | 51 | 22 | 2 | MM15151 | |
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 15272007 | ||
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 16382098 | ||
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 15746173 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 5.92e-08 | 9 | 32 | 3 | 17884088 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.55e-07 | 12 | 32 | 3 | 30175250 | |
| Pubmed | 2.01e-07 | 13 | 32 | 3 | 15123669 | ||
| Pubmed | 3.19e-07 | 15 | 32 | 3 | 30970248 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 36769152 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 8.20e-07 | 2 | 32 | 2 | 37901435 | |
| Pubmed | X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model. | 8.20e-07 | 2 | 32 | 2 | 18259199 | |
| Pubmed | XIAP regulates intracellular ROS by enhancing antioxidant gene expression. | 8.20e-07 | 2 | 32 | 2 | 18692482 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 20427267 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 8.20e-07 | 2 | 32 | 2 | 26410685 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15888033 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 31438981 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 29250796 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9205126 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 18687476 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19570023 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16154537 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22065417 | ||
| Pubmed | XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland. | 8.20e-07 | 2 | 32 | 2 | 15540113 | |
| Pubmed | Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice. | 8.20e-07 | 2 | 32 | 2 | 25190756 | |
| Pubmed | Identification of an Xiap-like pseudogene on mouse chromosome 7. | 8.20e-07 | 2 | 32 | 2 | 19956646 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34739342 | ||
| Pubmed | IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. | 8.20e-07 | 2 | 32 | 2 | 29386580 | |
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 8.20e-07 | 2 | 32 | 2 | 16054936 | |
| Pubmed | Over-expression of X-linked inhibitor of apoptosis protein slows presbycusis in C57BL/6J mice. | 8.20e-07 | 2 | 32 | 2 | 18755525 | |
| Pubmed | Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. | 8.20e-07 | 2 | 32 | 2 | 12667469 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 33712547 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 33411788 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 31943325 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 12812761 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 28300832 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 29605544 | ||
| Pubmed | Overexpression of XIAP inhibits cisplatin-induced hair cell loss. | 8.20e-07 | 2 | 32 | 2 | 35026350 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 31841118 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11597143 | ||
| Pubmed | XIAP regulates cytosol-specific innate immunity to Listeria infection. | 8.20e-07 | 2 | 32 | 2 | 18769721 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21099289 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16115895 | ||
| Pubmed | XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice. | 8.20e-07 | 2 | 32 | 2 | 30585320 | |
| Pubmed | Eliminating encephalitogenic T cells without undermining protective immunity. | 8.20e-07 | 2 | 32 | 2 | 24277699 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 12042762 | ||
| Pubmed | Analysis of inhibitor of apoptosis protein family expression during mammary gland development. | 8.20e-07 | 2 | 32 | 2 | 20584313 | |
| Pubmed | XIAP inhibits gentamicin-induced hair cell damage and ototoxicity through the caspase-3/9 pathway. | 8.20e-07 | 2 | 32 | 2 | 33713642 | |
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 8.20e-07 | 2 | 32 | 2 | 37665666 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11313486 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34025452 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17881658 | ||
| Pubmed | X-linked inhibitor of apoptosis regulates T cell effector function. | 8.20e-07 | 2 | 32 | 2 | 18025200 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 18055022 | ||
| Pubmed | Skeletal muscle differentiation evokes endogenous XIAP to restrict the apoptotic pathway. | 8.20e-07 | 2 | 32 | 2 | 19333375 | |
| Pubmed | S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. | 2.46e-06 | 3 | 32 | 2 | 19273858 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 29771357 | ||
| Pubmed | Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. | 2.46e-06 | 3 | 32 | 2 | 11390657 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 38351372 | ||
| Pubmed | XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. | 2.46e-06 | 3 | 32 | 2 | 16566922 | |
| Pubmed | Quercetin ameliorates XIAP deficiency-associated hyperinflammation. | 2.46e-06 | 3 | 32 | 2 | 35687753 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 15258565 | ||
| Pubmed | Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils. | 2.46e-06 | 3 | 32 | 2 | 27735938 | |
| Pubmed | MiR-96 promotes myocardial infarction-induced apoptosis by targeting XIAP. | 2.46e-06 | 3 | 32 | 2 | 33752931 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 24395041 | ||
| Pubmed | The X-linked inhibitor of apoptosis regulates long-term depression and learning rate. | 2.46e-06 | 3 | 32 | 2 | 27189977 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 19595300 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 26825770 | ||
| Pubmed | Interaction of checkpoint kinase 1 and the X-linked inhibitor of apoptosis during mitosis. | 2.46e-06 | 3 | 32 | 2 | 14759516 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 32845893 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 21709246 | ||
| Pubmed | Inhibitor of apoptosis proteins are required for effective fusion of autophagosomes with lysosomes. | 2.46e-06 | 3 | 32 | 2 | 29743550 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 12395105 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28518218 | ||
| Pubmed | FAIM-L regulation of XIAP degradation modulates Synaptic Long-Term Depression and Axon Degeneration. | 2.46e-06 | 3 | 32 | 2 | 27767058 | |
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 2.46e-06 | 3 | 32 | 2 | 24704313 | |
| Pubmed | The Sept4 septin locus is required for sperm terminal differentiation in mice. | 2.46e-06 | 3 | 32 | 2 | 15737931 | |
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 2.46e-06 | 3 | 32 | 2 | 28117367 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 23928917 | ||
| Pubmed | Involvement of the Edar signaling in the control of hair follicle involution (catagen). | 2.46e-06 | 3 | 32 | 2 | 17148670 | |
| Pubmed | Caspase-3 Regulates YAP-Dependent Cell Proliferation and Organ Size. | 2.46e-06 | 3 | 32 | 2 | 29775577 | |
| Pubmed | Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia. | 2.46e-06 | 3 | 32 | 2 | 12973017 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 17928448 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 24335231 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 24422988 | ||
| Pubmed | Sept4/ARTS is required for stem cell apoptosis and tumor suppression. | 2.46e-06 | 3 | 32 | 2 | 20952537 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 2.46e-06 | 3 | 32 | 2 | 31054517 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 20129247 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 3.79e-06 | 33 | 32 | 3 | 22357600 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 17537961 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 35031483 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 29578003 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 19473982 | ||
| Pubmed | Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. | 4.92e-06 | 4 | 32 | 2 | 15798218 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 21156207 | ||
| Pubmed | Sept4/ARTS regulates stem cell apoptosis and skin regeneration. | 4.92e-06 | 4 | 32 | 2 | 23788729 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 31756561 | ||
| Pubmed | X-Linked inhibitor of apoptosis protein is involved in mutant SOD1-mediated neuronal degeneration. | 4.92e-06 | 4 | 32 | 2 | 12153481 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 15207275 | ||
| Pubmed | Unique anti-apoptotic activity of EAAC1 in injured motor neurons. | 4.92e-06 | 4 | 32 | 2 | 16858406 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 19897582 | ||
| Interaction | SCN11A interactions | 1.34e-06 | 15 | 30 | 3 | int:SCN11A | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.95e-07 | 9 | 25 | 3 | 1203 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 5.11e-05 | 8 | 25 | 2 | 419 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP | 4.19e-06 | 200 | 32 | 5 | M8045 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.65e-07 | 177 | 32 | 5 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-06 | 164 | 32 | 4 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-06 | 166 | 32 | 4 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.30e-06 | 175 | 32 | 4 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.30e-06 | 175 | 32 | 4 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 186 | 32 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 193 | 32 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 193 | 32 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 193 | 32 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 199 | 32 | 4 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 199 | 32 | 4 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 156 | 32 | 3 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.88e-04 | 156 | 32 | 3 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 156 | 32 | 3 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 156 | 32 | 3 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 159 | 32 | 3 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.99e-04 | 159 | 32 | 3 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 162 | 32 | 3 | 0cee9ef405765f3f82d0cd7b8adc88f6e9fdbb5c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-04 | 164 | 32 | 3 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-04 | 164 | 32 | 3 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-04 | 168 | 32 | 3 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-04 | 169 | 32 | 3 | da3485d77bb7876fad4f166f6099e681b27457ae | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.43e-04 | 170 | 32 | 3 | e0429f45a3639a10294ceb492f2286c495481c2b | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 171 | 32 | 3 | 1018d7bd378ce20bee56a77d5851b3538c55098c | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 171 | 32 | 3 | 173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 171 | 32 | 3 | 6bda333bb751d7835a04f21ac959eea79f2516aa | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-04 | 173 | 32 | 3 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-04 | 173 | 32 | 3 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 175 | 32 | 3 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 175 | 32 | 3 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.78e-04 | 178 | 32 | 3 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | 30efe1f0394c0edb27b91890b5c4637b73cbc5ec | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 180 | 32 | 3 | 310a311c3ed924c912a800cf287a825de44b8775 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 181 | 32 | 3 | 0bc58c8942491e7ee5b858c5742770df7677532f | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 182 | 32 | 3 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 183 | 32 | 3 | 745271bfe15e94a58157cd97d771e610f964341b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-04 | 185 | 32 | 3 | 5fd4a3776259c96cf2dcb87f050af8226acbbda9 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-04 | 185 | 32 | 3 | 4c55fa96877ab9a00fcbec3fb70fd2208d222527 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 186 | 32 | 3 | 459a7e97bbac2b2cd253aa4ab38d0e4ae6191e8b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.16e-04 | 186 | 32 | 3 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.16e-04 | 186 | 32 | 3 | a0cc925af97e47efd0c9bc17c37963e8ad4e5b35 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | (7)_DC_1|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.26e-04 | 188 | 32 | 3 | 832887afa4a54ed80906bc02176d646529c13398 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.26e-04 | 188 | 32 | 3 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 189 | 32 | 3 | 9e3c083174a64ea78648c6d48498fc4e721b569f | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 189 | 32 | 3 | b491204cf38dc80a2583e3082a82dda8d77b3fc4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.31e-04 | 189 | 32 | 3 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 189 | 32 | 3 | 6e19bfa52406ebe095daa99f958ec4d596ce6e39 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 3.36e-04 | 190 | 32 | 3 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-04 | 191 | 32 | 3 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 193 | 32 | 3 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 193 | 32 | 3 | 9fd2bc726bddf414f3de1c7a5ffd9317d3c98e29 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-04 | 194 | 32 | 3 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-04 | 194 | 32 | 3 | 024568d8a862f0fe4da1f66a58c6e71f0e8279f3 | |
| ToppCell | Monocytes-C1QA+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.57e-04 | 194 | 32 | 3 | 3e104e85574894c04791252d466d438fc809dde3 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-04 | 195 | 32 | 3 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-DC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.62e-04 | 195 | 32 | 3 | 143093edefb3da63bb10adb1f5ea6e250a524ac2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-04 | 195 | 32 | 3 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-04 | 195 | 32 | 3 | 7dd0cb8f3753fe761fac200cbd161708b6528c51 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-04 | 195 | 32 | 3 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-04 | 195 | 32 | 3 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-04 | 195 | 32 | 3 | bbf5f79be4fcea754328f1af7ee5625075248100 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-04 | 196 | 32 | 3 | fd756b247b2d8a291e8e71bec6f1e463d6557536 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 379132e944be2b9dcdf1a787293a48313956902c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 197 | 32 | 3 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | COVID-granulo1-|COVID / Condition, Cell_class and T cell subcluster | 3.73e-04 | 197 | 32 | 3 | 190392117dc6269a21983bd3e554066fd48acd5e | |
| ToppCell | COVID-granulo1|COVID / Condition, Cell_class and T cell subcluster | 3.73e-04 | 197 | 32 | 3 | 4cd774d9d5a6bf7729dc6b7bcd3ddfe3f3051ada | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.79e-04 | 198 | 32 | 3 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-04 | 198 | 32 | 3 | 00a54af5267bfe0eeab6720bf890dc4b6b803bfd | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.79e-04 | 198 | 32 | 3 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.79e-04 | 198 | 32 | 3 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | 243109377d62d20c69e9d1fedc252156e90cda1e | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.79e-04 | 198 | 32 | 3 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 3.85e-04 | 199 | 32 | 3 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-04 | 199 | 32 | 3 | 7648860058eec66019b574ad840d6f5cfa4476d9 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-IM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-04 | 199 | 32 | 3 | b3267d5a7ae0461f5e9e6a3ab6783317a8c42506 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-04 | 199 | 32 | 3 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-IM-IM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-04 | 199 | 32 | 3 | 01dacee8bb392639d475be3cb27ba3eeff1e57f1 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.90e-04 | 200 | 32 | 3 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | c210b98a75ab5d899d7278bc9b577f76a0b3970c | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.90e-04 | 200 | 32 | 3 | 33c5615cbedb9e14f4433169babd3a3a51f69b4c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | f0e7c2f07a7065511bf0b6521ce2e74e04e48544 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| Drug | Phenytoin | 1.91e-06 | 2 | 32 | 2 | DB00252 | |
| Drug | Wy-41,770 | 5.74e-06 | 3 | 32 | 2 | CID000165241 | |
| Drug | bendamustine | 1.90e-05 | 37 | 32 | 3 | CID000065628 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.02e-07 | 10 | 29 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.02e-07 | 10 | 29 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.87e-07 | 12 | 29 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | cathepsin L1 measurement | 1.11e-04 | 16 | 29 | 2 | EFO_0010619 | |
| Disease | sphingomyelin measurement | 1.52e-04 | 278 | 29 | 4 | EFO_0010118 | |
| Disease | esterified cholesterol measurement | 2.68e-04 | 128 | 29 | 3 | EFO_0008589 | |
| Disease | neuroimaging measurement | 5.18e-04 | 1069 | 29 | 6 | EFO_0004346 | |
| Disease | epilepsy (implicated_via_orthology) | 5.44e-04 | 163 | 29 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | human papilloma virus infection, oral cavity cancer | 7.84e-04 | 42 | 29 | 2 | EFO_0001668, EFO_0005570 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKARWYEWLDPSIKK | 46 | Q99459 | |
| LIKWKDLPYDQCTWE | 611 | Q8TDI0 | |
| WKPWEHIYSLCKAVK | 171 | Q8N7X0 | |
| NLDHTKPCWYWDKKD | 16 | O75909 | |
| KPCWYWDKKDLAHTP | 21 | O75909 | |
| VWKRWKHLDPACAAD | 36 | P59037 | |
| YDCKVEHWGLDKPLL | 186 | P01909 | |
| LKLCHPEWKSGDYWI | 1286 | P02458 | |
| ASLWGPYKDIWHKVG | 11 | Q92621 | |
| PKGKKAWCWASYLEE | 226 | Q96JM7 | |
| HGWYGWVKKELEKIP | 21 | O75884 | |
| YKEKPIDWLLDHILW | 316 | Q9UM21 | |
| HGKWPVKWYAPECIN | 531 | P43405 | |
| KHKWWPKNGQCDLYS | 801 | O43424 | |
| PLWRRHCKKYWLISE | 51 | Q9UK99 | |
| IKTWNIGKCELYHWV | 41 | Q7Z6Z7 | |
| WEQHAKWYPGCKYLL | 56 | Q96P09 | |
| FILLWHLCWPKEKAD | 181 | Q9H665 | |
| KVSWDWKDPYEVGHS | 61 | O15033 | |
| GDCVVYTLPAKKWHW | 26 | Q4AE62 | |
| IYKLWPEASKVKVHW | 531 | Q9NZJ4 | |
| WAGDWFVCPEKTLLH | 926 | O75923 | |
| YKVDVLPWIICKGDW | 416 | B1AKI9 | |
| EGDGWVYHKPLWKII | 726 | Q9BXB4 | |
| WKAYNPGWPHCLDEK | 151 | O15296 | |
| YLSWKSGPGEVKHWK | 371 | O43581 | |
| APGKVWWRLRKTCYH | 1186 | Q14524 | |
| LIWDCSPYWLKVKHV | 746 | P35498 | |
| PWEQHAKWYPGCKYL | 316 | P98170 | |
| LIWECHPYWIKLKEI | 731 | Q9UQD0 | |
| TEWLPHSWLQCKALY | 326 | Q96BW9 | |
| AWCKKWGVPIEKIYN | 731 | P11387 | |
| KHFFPKWLQVLCSWL | 656 | Q9UBB9 |